Abstract
Background It has been demonstrated that antiretroviral therapy improves health and lengthens the life of HIV positive individuals. For those living with HIV, attaining optimal adherence is turning out to be the largest obstacle. The purpose of this research was to determine how often antiretroviral therapy non-adherence is among HIV patients who visit Rwanda’s Kibungo Referral Hospital.
Methods This study utilized a quantitative, cross-sectional design. Data collection was conducted from March 25th to April 30, 2024, with a sample size of 396 HIV patients on ART at Kibungo Referral Hospital. Inclusion criteria included patients aged 18 years and older who had been on ART for six months, while exclusion criteria included lack of consent and hospitalized patients. A structured questionnaire was used. The Fisher exact test and logistic regression were employed to analyze associations, with significance set at p < 0.05 and 95% CI.
Findings The findings showed that the overall non-adherence rate to ART was 13% while the adherence rate was 87%. Also, patients without tertiary education are significantly more likely to be non-adherent to ART compared to those with tertiary education (AoR: 8.232, 95% CI: 4.124-17.217, P-value: <0.001). Patients who experience stigma are more likely to be non-adherent to ART (AoR: 2.148, 95% CI: 1.032-6.689, P-value: 0.015). Patients who perceive ART as ineffective are significantly more likely to be non-adherent (AoR: 9.333, 95% CI: 2.108-20.638, P-value: <0.001. Patients who do not integrate ART into their daily routines are significantly more likely to be non-adherent (AoR: 11.180, 95% CI: 5.879-28.338, P-value: <0.001). There is no significant association between not setting an alarm and non-adherence.
In conclusion The study found a high non-adherence rate to ART among HIV patients at Kibungo Referral Hospital, linked to factors such as younger age, lack of tertiary education, stigma, and perceived ineffectiveness of ART. It recommends implementing structured support systems and targeted interventions to improve adherence and health outcomes for these patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was obtained for this study
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research was carried out in accordance with the Declaration of Helsinki and received approval from the Mount Kenya University Ethical Review Board (Reference number: MKU/ETHICS/23/01/2024(1)).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Dataset was not share due to privacy of participants.
